Hypercalcitoninaemia in pseudohypoparathyroidism type 1A and type 1B

Επιστημονική δημοσίευση - Άρθρο Περιοδικού uoadl:3106545 33 Αναγνώσεις

Μονάδα:
Ερευνητικό υλικό ΕΚΠΑ
Τίτλος:
Hypercalcitoninaemia in pseudohypoparathyroidism type 1A and type 1B
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Pseudohypoparathyroidism (PHP) is a heterogeneous group of rare endocrine disorders characterised by normal renal function and renal resistance to the action of the parathyroid hormone. Type 1A (PHP1A), which is the most common variant, also include developmental and skeletal defects named as Albright hereditary osteodystrophy (AHO). We present two cases, a 54- and a 33-year-old male diagnosed with PHP who were referred to us for persistently high levels of serum calcitonin. AHO and multinodular goitre were present in the 54-year-old male, while the second patient was free of skeletal deformities and his thyroid gland was of normal size and without nodular appearance. We performed GNAS molecular analysis (methylation status and copy number analysis by MS-MLPA) in genomic DNA samples for both patients. The analysis revealed a novel missense variant c.131T>G p.(Leu44Pro) affecting GNAS exon 1, in the patient with the clinical diagnosis of PHP1A. This amino acid change appears to be in accordance with the clinical diagnosis of the patient. The genomic DNA analysis of the second patient revealed the presence of the recurrent 3-kb deletion affecting the imprinting control region localised in the STX16 region associated with the loss of methylation (LOM) at the GNAS A/B differentially methylated region and consistent with the diagnosis of an autosomal dominant form of PHP type 1B (PHP1B). In conclusion, hypercalcitoninaemia may be encountered in PHP1A and PHP1B even in the absence of thyroid pathology. © 2019 The authors.
Έτος δημοσίευσης:
2019
Συγγραφείς:
Yavropoulou, M.P.
Chronopoulos, E.
Trovas, G.
Avramidis, E.
Elli, F.M.
Mantovani, G.
Zebekakis, P.
Yovos, J.G.
Περιοδικό:
Endocrinology, Diabetes and Metabolism Case Reports
Εκδότης:
BioScientifica Ltd
Τόμος:
2019
Αριθμός / τεύχος:
1
Λέξεις-κλειδιά:
alfacalcidol; calcitonin; calcium; calcium carbonate; cyclic AMP; genomic DNA; levothyroxine; parathyroid hormone; parathyroid hormone[1-34]; pentagastrin; phosphate; thyroglobulin antibody; thyroid peroxidase antibody; uric acid, adult; Article; autosomal dominant disorder; autosomal dominant inheritance; brachydactyly; case report; clinical article; copy number variation; disorders of hormone metabolism; echography; enzyme linked immunosorbent assay; fatigue; gene deletion; Gilbert disease; hand radiography; Hashimoto disease; human; hypercalcitoninaemia; hyperphosphatemia; hypocalcemia; inguinal hernia; male; methylation; middle aged; missense mutation; muscle weakness; myalgia; nodular goiter; ossification; osteopenia; priority journal; pseudohypoparathyroidism; scoliosis; tetany; thyroidectomy
Επίσημο URL (Εκδότης):
DOI:
10.1530/EDM-18-0125
Το ψηφιακό υλικό του τεκμηρίου δεν είναι διαθέσιμο.